Table 1.
Full sample |
Women currently using contraception |
Women not currently using contraception a |
|||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | p-value | |
Overallb | 4251 | 100% | 3178 | 75% | 1073 | 25% | |
Access and experiences of SRH | |||||||
Current method usedc | p < 0.001 | ||||||
No method | 1073 | 25% | 0 | 0% | 1073 | 100% | |
LARC methods | 767 | 18% | 767 | 24% | 0 | 0% | |
SARC methods | 1169 | 27% | 1169 | 36% | 0 | 0% | |
Condom and other methods | 1242 | 30% | 1242 | 39% | 0 | 0% | |
Source of SRH cared | p < 0.001 | ||||||
No SRH care | 756 | 19% | 535 | 18% | 221 | 23% | |
SRH but no contraceptive care | 1135 | 25% | 635 | 19% | 500 | 44% | |
Private contraceptive-specific SRH care | 1709 | 43% | 1469 | 49% | 240 | 23% | |
Public contraceptive-specific SRH care | 651 | 13% | 539 | 14% | 112 | 10% | |
Current insurance coverage | p < 0.001 | ||||||
None | 706 | 16% | 524 | 15% | 182 | 17% | |
Private | 1824 | 50% | 1444 | 53% | 380 | 42% | |
Public | 1721 | 34% | 1210 | 32% | 511 | 41% | |
Composite patient-centered contraceptive counseling experiencee | 0.59 | ||||||
No | 643 | 53% | 543 | 53% | 100 | 56% | |
Yes | 553 | 47% | 487 | 47% | 66 | 44% | |
Demographic characteristics | |||||||
Age | p < 0.001 | ||||||
15–19 y | 589 | 13% | 477 | 15% | 112 | 8% | |
20–29 y | 1788 | 41% | 1361 | 43% | 427 | 38% | |
30–39 y | 1350 | 29% | 998 | 29% | 352 | 31% | |
40–49 y | 524 | 16% | 342 | 14% | 182 | 23% | |
Race/ethnicity | 0.07 | ||||||
White, non-Hispanic | 1539 | 48% | 1213 | 49% | 326 | 45% | |
Black, non-Hispanic | 1159 | 19% | 825 | 17% | 334 | 22% | |
Other/multiple, non-Hispanic | 350 | 8% | 260 | 8% | 90 | 8% | |
Hispanic | 1203 | 25% | 880 | 25% | 323 | 25% | |
Federal poverty level | 0.02 | ||||||
0%–99% | 1665 | 36% | 1189 | 34% | 476 | 40% | |
100%–199% | 1526 | 37% | 1159 | 37% | 367 | 38% | |
200%–299% | 1060 | 27% | 830 | 29% | 230 | 22% | |
Nativity status | 0.84 | ||||||
US born | 3524 | 83% | 2643 | 83% | 881 | 83% | |
Foreign born | 725 | 17% | 534 | 17% | 191 | 17% | |
Relationship status | 0.07 | ||||||
Married | 1083 | 31% | 774 | 29% | 309 | 35% | |
Cohabitating | 670 | 18% | 532 | 19% | 138 | 15% | |
Not married or cohabitating | 2498 | 51% | 1872 | 51% | 626 | 50% | |
Educational attainment | 0.24 | ||||||
Not a high school graduate | 813 | 17% | 596 | 17% | 217 | 17% | |
High school graduate/GED | 1395 | 30% | 1023 | 29% | 372 | 34% | |
Some college | 1354 | 35% | 1036 | 36% | 318 | 32% | |
College graduate | 689 | 18% | 523 | 19% | 166 | 17% | |
Parity | 0.01 | ||||||
0 | 1619 | 40% | 1267 | 42% | 352 | 35% | |
1 or more | 2630 | 60% | 1910 | 58% | 720 | 65% | |
Sexual identity | 0.34 | ||||||
Straight | 3616 | 87% | 2683 | 86% | 933 | 88% | |
Not straight | 571 | 13% | 449 | 14% | 122 | 12% |
SRH, sexual and reproductive health; NSFG, National Survey of Family Growth; LARC, long-acting reversible methods; SARC, short-acting reversible methods; FPL, federal poverty level; IUD, intrauterine device; STI, sexually transmitted infection; PCCC, patient-centered contraceptive counseling.
Population includes all female respondents aged 15 to 49 at the time of interview who were under 300% of the FPL and who responded to the unfulfilled contraceptive preferences due to cost variables; population is weighted to reflect the female civilian population of the United States. Population excludes those who were sterile and whose partner was sterile for non-contraceptive purposes; those who used permanent methods such as tubal ligation, hysterectomy, or vasectomy as their most effective method; those who were not using any method of contraception and did not have a male sexual partner in the past 12 months; and those who were not using any method of contraception and were actively trying to become pregnant as a reason for not using contraception.
p-values represent significant differences from Pearson's χ2 tests of association comparing the distribution of women using contraception and women not using contraception who are not trying to get pregnant by each SRH and demographic variable.
Overall percentage represents the proportion of all women using and not using contraception
LARC methods include IUDs and hormonal implants (Norplant, Implanon, or Nexplanon). SARC methods include pills, Depo-Provera and other injectables, the contraceptive patch (Ortho-Evra or Xulane), and the vaginal contraceptive ring. Other methods include noncondom coital methods such as withdrawal, the diaphragm, foam, jelly or cream, and emergency contraception; natural family planning methods such as periodic abstinence, cervical mucus tests, temperature rhythm, or calendar rhythm; and other nonspecified methods.
Source of SRH care categorizes the clinic where the respondents received SRH care in the past 12 months. This includes gynecologic care, pregnancy care, STI care and contraceptive care. Contraceptive care includes contraceptive methods, contraceptive counseling, or a check-up related to contraceptive use.
The composite PCCC measure combines all 4 patient-centered care items to create a dichotomous variable that considered those who rated their provider as “excellent” on all 4 characteristics to have received patient-centered contraceptive counseling, while those who rated their provider as anything less than “excellent” on any 1 of the 4 characteristics were considered to have not. This measure includes only respondents from survey years 2017–2019, as these were the only years this variable was asked in the NSFG.